Oral budesonide for the therapy of post-
โ
A. Sidney Barritt IV; Steven L. Zacks; Tara C. Rubinas; Hans H. Herfarth
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 442 KB
๐ 2 views
## Background: The therapy for posttransplant ibd is clinically challenging. patients receiving liver transplants are immunosuppressed to prevent rejection, but via an unknown mechanism develop de novo ibd in spite of receiving some of the same medications used for therapy in traditional ibd. in th